- Home
- MURA vs FUSB Comparison
MURA vs FUSB Comparison
Compare MURA & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- FUSB
- Stock Information
- Founded
- MURA 2013
- FUSB 1952
- Country
- MURA Ireland
- FUSB United States
- Employees
- MURA N/A
- FUSB N/A
- Industry
- MURA
- FUSB Major Banks
- Sector
- MURA
- FUSB Finance
- Exchange
- MURA Nasdaq
- FUSB Nasdaq
- Market Cap
- MURA 57.2M
- FUSB 65.8M
- IPO Year
- MURA N/A
- FUSB N/A
- Fundamental
- Price
- MURA $3.34
- FUSB $13.80
- Analyst Decision
- MURA Strong Buy
- FUSB
- Analyst Count
- MURA 4
- FUSB 0
- Target Price
- MURA $16.00
- FUSB N/A
- AVG Volume (30 Days)
- MURA 262.8K
- FUSB 4.9K
- Earning Date
- MURA 11-13-2024
- FUSB 01-23-2025
- Dividend Yield
- MURA N/A
- FUSB 1.61%
- EPS Growth
- MURA N/A
- FUSB 5.90
- EPS
- MURA N/A
- FUSB 1.40
- Revenue
- MURA N/A
- FUSB $40,310,000.00
- Revenue This Year
- MURA N/A
- FUSB N/A
- Revenue Next Year
- MURA N/A
- FUSB N/A
- P/E Ratio
- MURA N/A
- FUSB $9.77
- Revenue Growth
- MURA N/A
- FUSB 0.79
- 52 Week Low
- MURA $2.88
- FUSB $8.66
- 52 Week High
- MURA $6.25
- FUSB $14.30
- Technical
- Relative Strength Index (RSI)
- MURA 36.64
- FUSB 62.20
- Support Level
- MURA $3.32
- FUSB $13.41
- Resistance Level
- MURA $4.20
- FUSB $13.79
- Average True Range (ATR)
- MURA 0.23
- FUSB 0.40
- MACD
- MURA -0.08
- FUSB -0.05
- Stochastic Oscillator
- MURA 3.41
- FUSB 64.54
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.